CDK 4/6 Inhibitors in Metastatic Breast Cancer
0 Views
administrator
07/03/23
Hope S. Rugo, MD, discusses the use of CDK 4/6 inhibitors and their impact on the treatment paradigm for metastatic breast cancer.
-
Category
Show more
Facebook Comments
No comments found